Skip to main content

Table 1 Baseline characteristics of enrolled patients

From: A novel potential mechanism for the development of portal vein thrombosis in cirrhosis based on portal hemodynamics

Characteristic

With PVT (n = 36)

Without PVT (n = 36)

Gender, male (%)

28 (77.8%)

29 (80.6%)

Age, years

51 ± 10

51 ± 11

The etiology

  

 HBV

20

27

 HCV

5

2

 Alcohol

8

7

 Others

4

0

 PLT, × 109 /L

67 (44–96)

64 (40–86)

 Bilirubin, μmol /L

19.8 (13.9–27.3)

19.6 (15.2–27.5)

 Albumin, g/L

34.2 ± 5.3

34.0 ± 4.6

 ALT, IU/L

20 (16–24)

25 (16–40)

 AST, IU/L

21 (21–36)

32 (24–53)

 Creatinine, μmol /L

67 (56–79)

71 (62–85)

 PT, S

15.0 ± 1.9

14.7 ± 1.9

 INR

1.3 ± 0.2

1.3 ± 0.2

 MELD

10 (9–12)

10 (9–12)

Child–Pugh score

  

 A

12

7

 B

16

22

 C

8

7

EVL and/or EIS history

15

8

Ascites

  

Without ascites

7

4

  I

12

9

  II

3

9

  III

14

14

PPG, mmHg

22 ± 6

21 ± 5

  1. Data are presented as median (interquartile range) or number (percentage). PVT, portal vein thrombosis; HBV, hepatitis B virus; HCV, hepatitis B virus; PLT, platelet count; ALT, alanine aminotransferase; AST, aspartate aminotransferase; PT, prothrombin time; INR, international normalized ratio; MELD, model for end-stage liver disease; EVL, endoscopic variceal ligation; EIS, endoscopic injection sclerotherapy; PPG, portal pressure gradient